170277-31-3 Usage
Uses
Infliximab targets the transcription factor NF-κB with harmine and related compounds for treatment of cancers and inflammatory diseases and combination with other agents
Check Digit Verification of cas no
The CAS Registry Mumber 170277-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,2,7 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 170277-31:
(8*1)+(7*7)+(6*0)+(5*2)+(4*7)+(3*7)+(2*3)+(1*1)=123
123 % 10 = 3
So 170277-31-3 is a valid CAS Registry Number.